Evidence for cross talk between PPARα and p38 MAP kinase

Toxicological Sciences

Volumn 68, Issue 2, 2002, Pages 270-274

  Roberts, Ruth A ^a,b  

^a JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SYNAPTOPHYSIN; XENOBIOTIC AGENT; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CARCINOGEN; CELL RECEPTOR; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRIDINE DERIVATIVE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; LIVER CARCINOGENESIS; MEDICAL TECHNOLOGY; MOUSE; NONHUMAN; PEROXISOME; PLEIOTROPY; PROTEIN PHOSPHORYLATION; RODENT; SIGNAL TRANSDUCTION; ANIMAL; CHEMICALLY INDUCED DISORDER; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL; LIVER TUMOR; METABOLISM; RAT; REVIEW;

ANIMAL; CARCINOGENS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; IMIDAZOLES; LIVER NEOPLASMS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PEROXISOME PROLIFERATORS; PYRIDINES; RATS; RECEPTOR CROSS-TALK; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; ANIMALS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

ANIMALIA; RODENTIA;

EID: 0036667350     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/68.2.270     Document Type: Article

References (60)

1. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription
2. Hepatic expression of acute-phase protein genes during carcinogenesis induced by peroxisome proliferators
3. Regulation of gene expression by fatty acids and fibric acid derivatives: An integrative role for peroxisome proliferator activated receptors. The Belgian Endocrine Society Lecture 1992
4. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene
5. p38 Mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: A potential role in the cardiac metabolic stress response
6. The p38/RK mitogen-activated protein kinase pathway regulates IL6 synthesis in response to tumor necrosis factor alpha
7. Antibodies to tumor necrosis factor-alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY 14,643
8. Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis
9. Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens
10. Cloning genes responsive to a hepatocarcinogenic peroxisome proliferator chemical reveals novel targets of regulation
11. Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators
12. Biology of interleukin 1
13. Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR)
14. Tumour necrosis factor alpha and interleukin-1 signaling: Do MAPKK kinases connect it all?
15. The organization, promoter analysis, and expression of the human PPARgamma gene
16. TNFα is not required for Wy-14, 643-induced proliferation in mice
17. Nuclear receptors and chemical carcinogenesis
18. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression
19. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: Role of PPARalpha and TNFalpha
20. Downregulation of lactoferrin by PPARα ligands: Role in perturbation of hepatocyte proliferation and apoptosis
21. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III
22. Tumour necrosis factor α (TNFα): Role in suppression of apoptosis by peroxisome proliferator nafenopin
23. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
24. The peroxisome proliferator-activated receptor: Retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs
25. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers
26. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
27. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
28. Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation
29. Dexamethasone selectively inhibits WY14, 643-induced cell proliferation and not peroxisome proliferation in mice
30. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
31. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
32. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver
33. Estrogen receptors: Orchestrators of pleiotropic cellular responses
34. The extracellular signal-regulated kinase pathway contributes to mitogenic and antiapoptotic effects of peroxisome proliferators in vitro
35. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid
36. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators
37. Novel sequence determinants in peroxisome proliferator signalling
38. Phosphorylation of peroxisome proliferator-activated receptor alpha in rat Fao cells and stimulation by ciprofibrate
39. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice
40. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator WY-14,643
41. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phophorylation on tyrosine and threonine
42. Peroxisome proliferators: Mechanisms of adverse effects in rodents and molecular basis for species differences
43. PPAR alpha and the regulation of cell division and apoptosis
44. Role of cytokines in nongenotoxic hepatocarcinogenesis: Cause or effect?
45. Cytokines and nongenotoxic hepatocarcinogenesis
46. Biology and toxicology of PPAR alpha ligands: The hypolipidaemic peroxisome proliferators
47. Exposure to peroxisome proliferators: Reassessment of the potential carcinogenic hazard
48. Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells
49. Tumour necrosis factor alpha (TNF-alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: A mediator of the hepatocarcinogenicity of peroxisome proliferators?
50. Kupffer cells are causally responsible for the mitogenic effects of peroxisome proliferators
51. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
52. Role of the peroxisome proliferator activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
53. The peroxisome proliferator-activated receptor alpha is a phosphoprotein: Regulation by insulin
54. Peroxisome proliferator-activated receptors: Structures and function
55. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene
56. Peroxisome proliferator-activated receptors (PPARs) and carcinogenesis
57. Identification of a novel peroxisome proliferator responsive cDNA isolated from rat hepatocytes as the zinc-finger protein ZFP-37
58. Role for tumour necrosis factor alpha receptor 1 and interleukin 1 receptor in the suppression of apoptosis by peroxisome proliferator nafenopin
59. Microarray analysis of gene expression changes in mouse liver induced by PPAR alpha agonists
60. Cross talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPAR alpha) signaling pathways. Growth hormone inhibition activity mediated by stat56